India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
Vikram-1, it is the country’s first ever private orbital rocket developed and designed indigenously. As…
India is advancing its access to the formal financial services, as Reserve Bank of India…
In the FIFA World Cup 2026, either Spain or Argentina will lift the ultimate trophy…
The Serum Institute of India (SII) has reached a watershed agreement with the Gates Medical…
Karnataka has made public the draft Karnataka Apartment (Ownership and Management) Bill, 2025 (KAOMA), an…
Uttar Pradesh state government made an announcement of the two digital platforms, that are called…